InvestorsHub Logo
Post# of 251888
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 179052

Tuesday, 06/10/2014 11:24:33 AM

Tuesday, June 10, 2014 11:24:33 AM

Post# of 251888
Re: RCPT meets MS primary endpoint in phase-2 portion of trial

Will be interesting to see clinical trials data from other next generation S1P modulators, as there are differences between them regarding S1PR selectivity and potency and it remains to be determined which one has the best profile.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.